LEADER 00888nam0-22002891i-450 001 990001775170403321 005 20190529131424.0 035 $a000177517 035 $aFED01000177517 035 $a(Aleph)000177517FED01 035 $a000177517 100 $a20021010d1975----km-y0itay50------ba 101 0 $aita 200 1 $aCaracteristicas de la novela espanola durante la decada 1875-1885$fEnrique Jesus Miralles Garcia. 210 $aBarcelona$cUniversidad de Barcelona$d1975. 215 $a12 p.$d24 cm 610 0 $aLetteratura spagnola 676 $a860 700 1$aMiralles Garcia,$bEnrique Jesus$077173 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aLG 912 $a990001775170403321 952 $a60 OP. 98/51$b45315$fFAGBC 959 $aFAGBC 996 $aCaracteristicas de la novela espanola durante la decada 1875-1885$9408822 997 $aUNINA DB $aING01 LEADER 04359nam 22009373u 450 001 996339089003316 005 20230721022843.0 010 $a1-282-70153-3 010 $a9786612701535 010 $a1-84692-609-2 035 $a(CKB)1000000000799039 035 $a(EBL)480219 035 $a(OCoLC)457162464 035 $a(SSID)ssj0000778673 035 $a(PQKBManifestationID)12398314 035 $a(PQKBTitleCode)TC0000778673 035 $a(PQKBWorkID)10767741 035 $a(PQKB)10117291 035 $a(SSID)ssj0000402427 035 $a(PQKBManifestationID)11255339 035 $a(PQKBTitleCode)TC0000402427 035 $a(PQKBWorkID)10425411 035 $a(PQKB)10633590 035 $a(MiAaPQ)EBC480219 035 $a(EXLCZ)991000000000799039 100 $a20130418d2009|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTherapeutic Strategies in Diabetes$b[electronic resource] 210 $aOxford $cClinical Publishing$d2009 215 $a1 online resource (262 p.) 225 1 $aTherapeutic Strategies 300 $aDescription based upon print version of record. 311 $a1-904392-87-3 327 $aContents; Editors; Contributors; Preface; Part 1: Metabolic considerations; Chapter 1: Blood glucose lowering therapies; Chapter 2: Insulin analogues; Chapter 3: New developments in insulin administration; Chapter 4: Metformin: new understanding and uses for an old drug; Chapter 5: Glitazones and glitazars: targeting PPAR and PPAR in diabetes; Chapter 6: Incretin hormones and diabetes mellitus; Part 2: Cardiovascular considerations; Chapter 7: An overview of current lipid-lowering treatments; Chapter 8: Statins and fibrates in the treatment of diabetic dyslipidaemia 327 $aChapter 9: Managing blood pressure in diabetesChapter 10: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers; Chapter 11: Antiplatelet therapy in diabetes; Chapter 12: Diabetes and folic acid; Chapter 13: Medical treatment of symptomatic diabetic neuropathy; Abbreviations; Index 330 $aThe increasing incidence of type II diabetes, often in association with cardiovascular disease, constitutes one of the major healthcare challenges of the 21st century. However, physicians can now deploy a wide range of therapeutic agents, singly and in combination, to help lower and stabilise blood sugar levels. Drawing on the expertise of internationally-recognised authorities in their fields, this new volume describes the modes of action of each of these types of treatment and evaluates their effectiveness.In the first section of the book the authors review the various agents used to manage 410 0$aTherapeutic Strategies 606 $aDiabetes -- Chemotherapy 606 $aDiabetes -- Complications -- Treatment 606 $aDiabetes Complications -- therapy 606 $aDiabetes Mellitus -- therapy 606 $aHypoglycemic agents -- Therapeutic use 606 $aGlucose Metabolism Disorders 606 $aEndocrine System Diseases 606 $aDiabetes Mellitus 606 $aDiabetes Mellitus, Type 2 606 $aMetabolic Diseases 606 $aDiseases 606 $aNutritional and Metabolic Diseases 606 $aMedicine$2HILCC 606 $aClinical Endocrinology$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 4$aDiabetes -- Chemotherapy. 615 4$aDiabetes -- Complications -- Treatment. 615 4$aDiabetes Complications -- therapy. 615 4$aDiabetes Mellitus -- therapy. 615 4$aHypoglycemic agents -- Therapeutic use. 615 2$aGlucose Metabolism Disorders 615 2$aEndocrine System Diseases 615 2$aDiabetes Mellitus 615 2$aDiabetes Mellitus, Type 2 615 2$aMetabolic Diseases 615 2$aDiseases 615 2$aNutritional and Metabolic Diseases 615 7$aMedicine 615 7$aClinical Endocrinology 615 7$aHealth & Biological Sciences 676 $a616.462 700 $aSchaper$b N$01013659 701 $aStehouwer$b C.D.A$01013660 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339089003316 996 $aTherapeutic Strategies in Diabetes$92358175 997 $aUNISA